FindTrial
Sign In

A randomized controlled multicenter study on the effectiveness of digital medicine combined with preoperative conformal radiotherapy on the down-stage resection of hepatocellular carcinoma with portal vein tumor thrombus

A randomized controlled multicenter study on the effectiveness of digital medicine combined with preoperative conformal radiotherapy on the down-stage resection of hepatocellular carcinoma with portal vein tumor thrombus

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012510
Enrollment
Unknown
Registered
2017-08-31
Start date
2016-04-01
Completion date
Unknown
Last updated
2017-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

Preoperative radiotherapy group:Preoperative conformal radiotherapy
Surgery group:Surgery without preoperative radiotherapy

Sponsors

Eastern Hepatobiliary Surgery Hospital, Second Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Male or non-pregnant female patients diagnosed as hepatocellualr carcinoma with portal vein tumor thrombus(III/IV type of Cheng's classification); 2. Resectable lesion confirmed by 2 senior experts of hepatic surgery; 3. With no distant metastasis/insufficient liver function/dysfunction of other organs; 4. With no HCV or HIV infection.

Exclusion criteria

Exclusion criteria: 1. Unresectable lesion; 2. Underwent other invasive treatment.

Design outcomes

Primary

MeasureTime frame
Disease free survival;Overall survival;—

Secondary

MeasureTime frame
Response of tumor and tumor thrombus after radiation;—

Countries

China

Contacts

Public ContactCheng Shuqun

Eastern Hepatobiliary Surgery Hospital, Second Military Medical University

chengshuqun@aliyun.com+86 021 81875251

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026